Impact of the COVID-19 pandemic In ITS analyses of overall antidepressant sales, there was strong evidence for a slightly increasing trend before the pandemic (+0.02 DDD/TID per month, 95% CI 0.01 to 0.03), no evidence for an immediate change in May 2020 (+0.42 DDD/TID, 95% CI −0.39 to 1.24), and very strong evidence for an increase in trend of antidepressant sales after May 2020 (+0.20 DDD/TID per month, 95% CI 0.15 to 0.24; figure 2 , table 1 ).
← all excerpts
Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis.
1
—
—